AstraZeneca signs deal with Canada for 100000 doses of COVID drug

AstraZeneca plc signed an agreement with Canada for 100,000 doses of its antibody therapy for prevention of COVID-19 in some high-risk patients, the country's government said on Wednesday. AstraZeneca's Evusheld is under review by Health Canada for use as a preventive treatment against the disease in those who are immunocompromised. 'While vaccines provide excellent protection, people who are immunocompromised may need additional protection against COVID-19,' said Canadian health minister Jean-Yves Duclos.